These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11568763)

  • 21. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.
    Savin RC
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):807-9. PubMed ID: 2229529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acrodermatitis continua of Hallopeau due to oral terbinafine.
    Nishiwaki F; Matsumura Y; Morita N; Kore-Eda S; Miyachi Y; Omoto M
    Br J Dermatol; 2007 Nov; 157(5):1073-4. PubMed ID: 17854368
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral terbinafine-induced bullous pemphigoid.
    Aksakal BA; Ozsoy E; Arnavut O; Ali Gürer M
    Ann Pharmacother; 2003 Nov; 37(11):1625-7. PubMed ID: 14565807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy consisting of week pulses of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis.
    Sanmano B; Hiruma M; Mizoguchi M; Ogawa H
    J Dermatolog Treat; 2004 Jul; 15(4):245-51. PubMed ID: 15764040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two cases of acute generalized exanthematous pustulosis related to oral terbinafine and an analysis of the clinical reaction pattern.
    Eyler JT; Squires S; Fraga GR; Liu D; Kestenbaum T
    Dermatol Online J; 2012 Nov; 18(11):5. PubMed ID: 23217946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Terbinafine-induced persistent agueusia: first reported case].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Mar; 127(3):341. PubMed ID: 10804319
    [No Abstract]   [Full Text] [Related]  

  • 34. Terbinafine for onychomycosis.
    Med Lett Drugs Ther; 1996 Aug; 38(981):72-4. PubMed ID: 8699988
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute generalized exanthematous pustulosis induced by terbinafine.
    Taberner R; Puig L; Gilaberte M; Alomar A
    Eur J Dermatol; 2003; 13(3):313-4. PubMed ID: 12805000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onychomycosis and terbinafine.
    Lancet; 1990 Mar; 335(8690):636. PubMed ID: 1969022
    [No Abstract]   [Full Text] [Related]  

  • 37. Short-duration oral terbinafine for the treatment of tinea pedis in HIV-positive patients.
    Smith S; Houpt K; Rich P; LaMarca A; Weinberg JM; Alferez TS; Atillasoy E; Opper C
    Cutis; 2001 Jul; 68(1 Suppl):30-9. PubMed ID: 11499332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
    Gerasimchuk EV; Gerasimov VV; Molchanov BA
    Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
    [No Abstract]   [Full Text] [Related]  

  • 39. Inappropriate use of oral terbinafine in family practice.
    Wilcock M; Hartley J; Gould D
    Pharm World Sci; 2003 Feb; 25(1):25-6. PubMed ID: 12661473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the efficacy and tolerability of oral terbinafine in the treatment of onychomycosis in renal transplant patients.
    Lee KH; Kim YS; Kim MS; Chung HS; Park K
    Transplant Proc; 1996 Jun; 28(3):1488-9. PubMed ID: 8658754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.